Home > Boards > US Listed > Medical - Drugs > AVEO Pharmaceuticals, Inc. (AVEO)

AVEO looks good on the chart......8 SMA and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
cooljet Member Profile
 
Followed By 3
Posts 1,423
Boards Moderated 0
Alias Born 02/22/07
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/8/2019 4:05:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/8/2019 7:06:22 AM
AVEO Reports Second Quarter 2019 Financial Results and Provides Business Update Business Wire - 8/8/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 6:16:14 AM
Kyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO Oncology Business Wire - 8/1/2019 6:00:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 6/14/2019 8:03:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:02:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:01:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:01:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/13/2019 4:07:06 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/31/2019 5:12:42 PM
AVEO Oncology to Present at the 2019 BIO International Convention Business Wire - 5/29/2019 7:00:00 AM
AVEO Oncology Announces Presentations at the 2019 ASCO Annual Meeting Business Wire - 5/15/2019 5:00:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 5/10/2019 1:42:59 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 4:06:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 7:07:01 AM
AVEO Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire - 5/9/2019 7:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/1/2019 3:13:55 PM
AVEO Oncology to Participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit Business Wire - 5/1/2019 7:00:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 5:06:07 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 6:34:25 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 6:32:49 AM
AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA® in Spain Business Wire - 4/23/2019 4:05:00 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/19/2019 5:12:22 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/17/2019 2:24:36 PM
cooljet   Friday, 03/20/15 10:19:08 AM
Re: None
Post # of 4724 
AVEO looks good on the chart......8 SMA and 50 SMA is above the 200 SMA.......looking to take short term profits around $1.80- $1.95........

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist